COMPANY OVERVIEW

Developing safe and effective therapeutics for the treatment of orphan neurologic disease

---

LOCATION

San Francisco, CA, USA

---

THERAPEUTIC AREAS

Neurological DIsorders

Rare Diseases

---

WEBSITE

https://www.neurovia-inc.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jul 25, 2018

NeuroVia Initiates Phase 1/2 Trial of NV1205 for Treating Childhood Cerebral Adrenoleukodystrophy (CCALD)

Sep 28, 2017

NeuroVia Appoints Daniel Bradbury and Edward Kaye to its Board of Directors

Jul 20, 2017

NeuroVia Closes Series A Financing Round of $14M to Develop Novel Treatment Option for X-ALD Disease

For More Press Releases

---